AMICUS THERAPEUTICS INC
Industry: Life Sciences ・ $FOLD on Nasdaq
Insider Sale
+$4,000
-0.03%
Shares
Shares Volume: 400 Shares
Average Share Price: $10
INSIDER
Campbell Bradley L
President and CEO (Director)
reported on Feb 21 2025
traded on Feb 19 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,150,657 |
| PURCHASES/SALES 1Y | 0 / 12 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $84,652.76 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $135,802.04 |
| COMPANY PREVIOUS TRADES |